A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to...

Bile duct cancer is a rare but aggressive form of cancer, affecting just over 2,000 people in the UK every year. However, incidences of bile cancer are steadily increasing every year—with some estimating...

Help wanted ad: The Central Intelligence Agency (CIA) is looking for primary care specialists and psychiatrists “to keep our Nation safe,” a CIA online job ad says. The recent death of famed...

(HealthDay)—Angie Gaytan never cared much for beets, but beets sure do love her—doctors say that veggie shakes, fruits, beet juice and other healthy foods likely helped the 16-year-old defeat her...

WEDNESDAY, Oct. 21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. In...

Researchers at Mount Sinai have discovered that human acute myeloid leukemia (AML) stem cells are dependent on a transcription factor known as RUNX1, potentially providing a new therapeutic target to...